TD Cowen and H.C. Wainwright have raised price targets on KalVista Pharmaceuticals, expressing confidence in its oral hereditary angioedema treatment ahead of the company's fourth-quarter financial results.
A deep dive into the software company's valuation using a discounted cash flow model suggests its shares may be trading at a significant premium to their estimated intrinsic value.
Shares of PlayStudios fell sharply amid a broad gaming stock sell-off triggered by Google's unveiling of a real-time 3D world-generating AI, raising fears of industry disruption.
In a strategic move to unify its product and technology vision, Netflix has elevated CTO Elizabeth Stone to the newly created role of Chief Product and Technology Officer. The promotion places her at the helm of the streaming giant's core product, engineering, and data divisions.
WK Kellogg Co. names former Ferrero executive Jean-Baptiste Santoul as Chief Operating Officer, signaling a strategic shift following its $3.1 billion acquisition by the global confectionery giant.
The medical device developer Beta Bionics has received a warning letter from the U.S. Food and Drug Administration, a regulatory action stemming from a facility inspection last summer. The company maintains the letter will not disrupt its operations, manufacturing, or the planned launch of its new insulin patch pump.
In a strategic reshuffle following the exit of its product chief, Netflix has merged its product and technology divisions under veteran executive Elizabeth Stone, signaling a tighter integration of engineering and user experience.
While many AI stocks soared in 2025, Salesforce shares faced significant headwinds. Despite a challenging year, the cloud software giant's robust fundamentals and reasonable valuation suggest it may be poised for a recovery.
Craig-Hallum and Northland Securities have both lowered price targets for MiMedx Group (MDXG), citing near-term uncertainty following new CMS billing guidance for skin substitute products, though both firms maintain positive long-term ratings.
A discounted cash flow valuation of GrainCorp Limited suggests its current share price may not fully reflect its future cash generation potential, indicating a possible opportunity for investors.
Abbott Laboratories moves to acquire cancer-testing leader Exact Sciences in a landmark deal, signaling a strategic shift toward high-growth diagnostics while simultaneously restructuring its challenged Nutrition business.
Novo Nordisk launches its first oral GLP-1 weight-loss drug with strong early demand, reports positive Phase 3 results for CagriSema, and expands a cell therapy partnership for diabetes. These moves come as investors reevaluate the company's long-term growth prospects amid competitive and pricing pressures.
Bank of America's stock has retreated roughly 5% over the past month, trading below key fair value estimates. Analysts are divided on whether this presents a value entry point or reflects growing market apprehension about interest margins and credit quality.
As inflation persists, Baby Boomers are leveraging decades of financial experience to cut costs strategically. We examine the key spending categories they avoid and the generational mindset behind their money choices.
As global leaders gather in Davos, a coalition of over 400 affluent individuals from 24 nations issues a stark demand: governments must impose higher taxes on the ultra-wealthy to tackle inequality.
A new study reveals the cost gap between Waymo's driverless vehicles and human-driven Uber and Lyft rides is shrinking, signaling a pivotal moment for the competitive robotaxi industry.
A broad sell-off in risk assets, from equities to precious metals, has triggered over $2.5 billion in Bitcoin liquidations. Analysts point to shifting Federal Reserve expectations and AI trade anxieties as key drivers behind the latest crypto market tremor.
CNBC's Jim Cramer lauds Salesforce's operational strength, yet the stock, alongside peer ServiceNow, faces persistent 'multiple compression' as Wall Street reevaluates growth expectations for mature software leaders.
CNBC's Jim Cramer spotlighted Royal Caribbean Cruises Ltd. (RCL) this week, praising its ambitious full-year 2026 forecast as the cruise line capitalizes on robust post-pandemic demand and operational efficiencies.
CNBC's Jim Cramer concedes he misjudged the explosive demand for Apple's iPhone 17, which powered the tech giant to a staggering earnings beat that caught Wall Street off guard.
